{"id":447037,"title":"Notice of Amendment: List of Opioids (Part A): Buprenorphine and Methadone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T13:26:30.468000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/opioids-a-buprenorphine-methadone.html?wbdisable=false","snippet":"Notice of Amendment: List of Opioids (Part A): Buprenorphine and Methadone Date: October 1, 2018 The purpose of this Notice of Amendment is to notify stakeholders that Health Canada has amended Part A of the List of Opioids . A qualifier has been added to the list to exempt…","rawSnapshotUrl":"/api/snapshots/raw/447037","browseUrl":"https://replay.healtharchive.ca/job-6/20260103132630/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/opioids-a-buprenorphine-methadone.html?wbdisable=false#ha_snapshot=447037","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}